By Kamal Choudhury and Sahil Pandey Feb 5 (Reuters) - Healthcare data and clinical research provider IQVIA Holdings on Thursday defended its AI strategy against analyst concerns that recent technology ...

Feb 5 (Reuters) - Healthcare data and clinical research provider IQVIA Holdings on Thursday forecast annual profit below Wall Street expectations, weighed down by higher interest costs, even as strong ...

Clinical research company IQVIA (NYSE: IQV) reported Q4 CY2025 results , with sales up 10.3% year on year to $4.36 billion.

IQVIA (NYSE:IQV) shares slid Thursday. The company, priding itself on being “a leading global provider of clinical research ...

IQVIA and its Data-as-a-Service (DaaS+) technology have been chosen by Boehringer Ingelheim in a new, strategic long-term ...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV) today announced the launch of One Home for Sites™, a new technology platform that acts as a single sign-on and a single dashboard for ...

Shares of clinical research company IQVIA (NYSE: IQV) fell 8.5% in the morning session after the company issued a weak full-year 2026 profit forecast that fell below Wall Street expectations.

IQVIA Holdings Inc. IQV yesterday unveiled a clinical trial technology platform, One Home for Sites. The platform streamlines the process of management of trials by acting as a single sign-on and a ...

IQVIA (IQV) stock slips and its peers also slide as the company set its full-year earnings outlook below Street forecasts despite a Q4 2025 beat. Read more here.

Bold initiative to boost the capacity of research sites enters Beta testing and piloting RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA (NYSE:IQV) today announced the launch of One Home for ...